These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 7834677
1. [Comparison of the effects of omega-3 polyunsaturated fatty acids and Olbetam (Acipimox) in the treatment of hypertriglyceridemia]. Zák A, Zeman M, Vítková D. Cas Lek Cesk; 1994 Dec 22; 133(24):755-8. PubMed ID: 7834677 [Abstract] [Full Text] [Related]
2. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia]. Yeshurun D, Hamood H, Morad N, Naschitz J. Harefuah; 2000 Apr 16; 138(8):650-3, 710. PubMed ID: 10883206 [Abstract] [Full Text] [Related]
3. [Personal experience with the hypolipidemic agent Olbetam-Acipimox in hyperlipoproteinemia associated with type II diabetes]. Rajecová E, Kréze A, Klimes I, Cvrkalová A, Lacko A, Langrová H, Hanzen E. Cas Lek Cesk; 1991 Nov 29; 130(22-23):661-3. PubMed ID: 1786587 [Abstract] [Full Text] [Related]
4. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia. Wohl DA, Tien HC, Busby M, Cunningham C, Macintosh B, Napravnik S, Danan E, Donovan K, Hossenipour M, Simpson RJ. Clin Infect Dis; 2005 Nov 15; 41(10):1498-504. PubMed ID: 16231263 [Abstract] [Full Text] [Related]
5. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia. Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L. Eur J Clin Nutr; 1994 Dec 15; 48(12):859-65. PubMed ID: 7889894 [Abstract] [Full Text] [Related]
6. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia]. Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P. Cardiologia; 1993 Dec 15; 38(12):773-8. PubMed ID: 8200011 [Abstract] [Full Text] [Related]
7. [The effect of fish oil on metabolic parameters in patients with type 2 diabetes mellitus associated with dyslipidemia]. Zák A, Zeman M, Tvrzická E, Stolba P. Cas Lek Cesk; 1996 May 29; 135(11):354-9. PubMed ID: 8706072 [Abstract] [Full Text] [Related]
8. [Effect of fibrates on VLDL and LDL lipoprotein composition and parameters of their oxidation in hypertriglyceridemia]. Zeman M, Zák A, Tvrzická E, Konárková M, Stípek S. Cas Lek Cesk; 2002 Apr 12; 141(7):211-6. PubMed ID: 12053756 [Abstract] [Full Text] [Related]
9. Effects of omega-3 fatty acids in hypertriglyceridemic states. Connor WE. Semin Thromb Hemost; 1988 Jul 12; 14(3):271-84. PubMed ID: 3051392 [Abstract] [Full Text] [Related]
10. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. McKenney JM, Sica D. Pharmacotherapy; 2007 May 12; 27(5):715-28. PubMed ID: 17461707 [Abstract] [Full Text] [Related]
11. Safety and efficacy of Omacor in severe hypertriglyceridemia. Harris WS, Ginsberg HN, Arunakul N, Shachter NS, Windsor SL, Adams M, Berglund L, Osmundsen K. J Cardiovasc Risk; 1997 May 12; 4(5-6):385-91. PubMed ID: 9865671 [Abstract] [Full Text] [Related]
12. Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia. Paragh G, Balogh Z, Boda J, Kovács P, Kárpáti L, Szabó J, Leövey A. Acta Biol Hung; 1997 May 12; 48(3):359-67. PubMed ID: 9406614 [Abstract] [Full Text] [Related]
13. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR. Am J Cardiol; 2008 Aug 15; 102(4):429-33. PubMed ID: 18678300 [Abstract] [Full Text] [Related]
14. Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia. Nordøy A, Hansen JB, Brox J, Svensson B. Nutr Metab Cardiovasc Dis; 2001 Feb 15; 11(1):7-16. PubMed ID: 11383326 [Abstract] [Full Text] [Related]
15. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. De Luis DA, Conde R, Aller R, Izaola O, González Sagrado M, Perez Castrillón JL, Dueñas A, Romero E. Eur Rev Med Pharmacol Sci; 2009 Feb 15; 13(1):51-5. PubMed ID: 19364085 [Abstract] [Full Text] [Related]
16. [The hypolipemic effect of concentrated salmon oil rich in n-3 fatty acids]. Pérez Corral F, Perales J, Fraile G. An Med Interna; 1990 Jun 15; 7(6):299-303. PubMed ID: 2102734 [Abstract] [Full Text] [Related]
17. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Bays HE, Tighe AP, Sadovsky R, Davidson MH. Expert Rev Cardiovasc Ther; 2008 Mar 15; 6(3):391-409. PubMed ID: 18327998 [Abstract] [Full Text] [Related]
18. [The hypotriglyceridemic effects of polyunsaturated fatty acids: pathogenetic hypothesis]. Del Ponte A, Bitti G, Di Giacomo G, Marinari S. Riv Eur Sci Med Farmacol; 1995 Mar 15; 17(5):175-82. PubMed ID: 8766785 [Abstract] [Full Text] [Related]
19. [The effect of the spectrum fatty acids in plasma lipids on the hypolipidemic effect of fish oils in hyperlipidemic patients]. Zák A, Zeman M, Tvrzická E. Vnitr Lek; 1993 Jul 15; 39(7):682-9. PubMed ID: 8372464 [Abstract] [Full Text] [Related]
20. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio. Burns T, Maciejewski SR, Hamilton WR, Zheng M, Mooss AN, Hilleman DE. Pharmacotherapy; 2007 May 15; 27(5):633-8. PubMed ID: 17461697 [Abstract] [Full Text] [Related] Page: [Next] [New Search]